Quality built into every decision
Star Medical Distribution is developing its operation around patient safety, product integrity and regulatory accountability. Our facility, people and systems are being designed to support the requirements of UK Good Distribution Practice, controlled drug governance and responsible pharmaceutical wholesale distribution.
A quality-first operating model
Quality is being embedded from the outset through documented procedures, defined responsibilities, risk management, training, supplier oversight and continuous review. This approach is intended to make compliance part of everyday decision-making rather than a separate administrative exercise.
Regulated activities will begin only after the required licences and approvals have been secured.
Quality Management System
Our developing QMS covers supplier and customer qualification, document control, training, temperature management, deviations, CAPA, complaints, returns, recalls, change control, self-inspection and management review. These systems will provide the documented framework for consistent, accountable operations.
Regulatory compliance
Our licensing programme is structured around the requirements of the MHRA for a WDA(H) and the Home Office for controlled drug activities. We are working with experienced regulatory and quality professionals to develop the facility, documentation and governance required for inspection readiness.
Good Distribution Practice
Our facility, procedures and supply-chain controls are being designed to maintain product quality throughout receipt, storage, handling, order preparation and onward distribution. Clear records, temperature oversight and full traceability will support product integrity at every stage.
Controlled drug governance
Physical security, controlled access, accountable records, secure storage, incident response and diversion prevention are central to our controlled medicines model. These arrangements are being developed through risk assessment and will remain subject to Home Office approval.
Product security and traceability
Supplier qualification, batch-level records, environmental monitoring, stock reconciliation and documented chain-of-custody controls will support the integrity and traceability of products throughout the distribution process.
Continuous improvement
Quality performance will be reviewed through risk assessment, incident investigation, CAPA, internal audits, training, trend analysis and management review. Lessons will be documented and used to strengthen systems as the business and product portfolio develop.
Patient safety and supply continuity
Our quality framework is ultimately designed around two connected outcomes: protecting patients and helping our partners maintain a reliable supply of appropriate, quality-assured medicines. Every procedure and control should contribute meaningfully to those objectives.